• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体跨膜结构域的构象

Conformation of the transmembrane domain of the epidermal growth factor receptor.

作者信息

Brandt-Rauf P W, Monaco R, Pincus M R

机构信息

Division of Environmental Sciences, Columbia University, New York, New York 10032.

出版信息

J Protein Chem. 1994 Feb;13(2):227-31. doi: 10.1007/BF01891980.

DOI:10.1007/BF01891980
PMID:7914727
Abstract

The transmembrane domain of growth factor receptors, such as the epidermal growth factor receptor (EGFR) and the related c-erbB-2/neu oncogene protein, has been implicated in the process of receptor dimerization and mitogenic signal transduction, and hence in cellular transformation and oncogenesis. Amino acid substitutions in the transmembrane domain of the c-erbB-2/neu protein that cause a transforming effect may exert this effect through a conformational change from a bend conformation to an alpha-helical structure in this region of the protein, but similar amino acid substitutions at homologous positions in the transmembrane domain of the EGFR (e.g., Val-->Glu at position 627) fail to have a transforming effect. To examine whether this failure may be due to structural effects, we have used conformational energy analysis to determine the preferred three-dimensional structures for the nonapeptide sequence of the transmembrane domain of the EGFR from residues 623-631 with Val or Glu at position 627. The global minimum energy conformations of both nonapeptides were found to be non-alpha-helical with bends at positions 624-625 and 627-628. The failure of the Val-->Glu substitution to produce a conformational change to an alpha-helix in this region may be responsible for its lack of transforming effect. However, the presence of higher energy alpha-helical conformations for the nonapeptide from the normal EGFR may provide an explanation for the presence of a transforming effect from overexpression of the EGFR.

摘要

生长因子受体的跨膜结构域,如表皮生长因子受体(EGFR)和相关的c-erbB-2/neu癌基因蛋白,已被认为参与受体二聚化和促有丝分裂信号转导过程,进而参与细胞转化和肿瘤发生。c-erbB-2/neu蛋白跨膜结构域中的氨基酸取代导致转化作用,可能是通过该蛋白此区域从弯曲构象到α螺旋结构的构象变化来发挥这种作用,但EGFR跨膜结构域同源位置的类似氨基酸取代(如第627位的Val→Glu)却没有转化作用。为了研究这种无效是否可能是由于结构效应,我们使用构象能量分析来确定EGFR跨膜结构域从第623 - 631位残基且第627位为Val或Glu的九肽序列的优选三维结构。发现两种九肽的全局最低能量构象均为非α螺旋结构,在第624 - 625位和第627 - 628位有弯曲。Val→Glu取代未能在该区域产生向α螺旋的构象变化,可能是其缺乏转化作用的原因。然而,正常EGFR九肽存在更高能量的α螺旋构象,这可能解释了EGFR过表达产生转化作用的原因。

相似文献

1
Conformation of the transmembrane domain of the epidermal growth factor receptor.表皮生长因子受体跨膜结构域的构象
J Protein Chem. 1994 Feb;13(2):227-31. doi: 10.1007/BF01891980.
2
Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
J Protein Chem. 1995 Jan;14(1):33-40. doi: 10.1007/BF01902842.
3
Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
J Protein Chem. 1989 Dec;8(6):749-56. doi: 10.1007/BF01024899.
4
Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.神经癌基因编码的p185蛋白跨膜结构域的结构与其功能的相关性。
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8660-4. doi: 10.1073/pnas.87.21.8660.
5
Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers.ErbB-2跨膜结构域内的Val(659)-->Glu突变:通过(2)H NMR在流体磷脂双分子层中测量的效应。
Biochemistry. 2000 May 30;39(21):6572-80. doi: 10.1021/bi000038o.
6
Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein.原癌基因和致癌形式的neu蛋白跨膜区的三维结构。
EMBO J. 1992 Jan;11(1):43-8. doi: 10.1002/j.1460-2075.1992.tb05025.x.
7
Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.p185c-neu受体酪氨酸激酶激活的跨膜结构域序列要求
J Cell Biol. 1997 May 5;137(3):619-31. doi: 10.1083/jcb.137.3.619.
8
Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.神经/表皮生长因子受体2(neu/erbB-2)受体二聚化及转化激活的跨膜结构域二聚体界面:分子动力学模拟揭示的模型
J Biomol Struct Dyn. 2001 Aug;19(1):15-31. doi: 10.1080/07391102.2001.10506717.
9
Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.特定的短跨膜序列在体外和体内均可抑制突变型神经生长因子受体介导的细胞转化。
Oncogene. 1993 Oct;8(10):2813-20.
10
Structural implications of a Val-->Glu mutation in transmembrane peptides from the EGF receptor.表皮生长因子受体跨膜肽中缬氨酸突变为谷氨酸的结构影响
Biophys J. 2001 Dec;81(6):3231-9. doi: 10.1016/S0006-3495(01)75958-9.

引用本文的文献

1
Structural implications of a Val-->Glu mutation in transmembrane peptides from the EGF receptor.表皮生长因子受体跨膜肽中缬氨酸突变为谷氨酸的结构影响
Biophys J. 2001 Dec;81(6):3231-9. doi: 10.1016/S0006-3495(01)75958-9.
2
Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
J Protein Chem. 1995 Jan;14(1):33-40. doi: 10.1007/BF01902842.

本文引用的文献

1
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.人表皮生长因子受体cDNA序列及扩增基因在A431表皮样癌细胞中的异常表达。
Nature. 1984;309(5967):418-25. doi: 10.1038/309418a0.
2
Role of medium-range interactions in proteins.中程相互作用在蛋白质中的作用。
Proc Natl Acad Sci U S A. 1973 Mar;70(3):830-3. doi: 10.1073/pnas.70.3.830.
3
The neu oncogene encodes an epidermal growth factor receptor-related protein.神经癌基因编码一种与表皮生长因子受体相关的蛋白质。
Nature. 1986;319(6050):226-30. doi: 10.1038/319226a0.
4
Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.人表皮生长因子受体的过表达赋予NIH 3T3细胞一种依赖表皮生长因子的转化表型。
Cell. 1987 Dec 24;51(6):1063-70. doi: 10.1016/0092-8674(87)90592-7.
5
Growth factor receptor tyrosine kinases.生长因子受体酪氨酸激酶
Annu Rev Biochem. 1988;57:443-78. doi: 10.1146/annurev.bi.57.070188.002303.
6
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.与表皮生长因子受体具有广泛同源性的酪氨酸激酶受体与neu癌基因位于同一染色体位置。
Science. 1985 Dec 6;230(4730):1132-9. doi: 10.1126/science.2999974.
7
Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.
Mol Cell Biol. 1988 Dec;8(12):5570-4. doi: 10.1128/mcb.8.12.5570-5574.1988.
8
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.通过点突变和缺失对neu编码的受体蛋白进行致癌激活。
EMBO J. 1988 Jul;7(7):2043-52. doi: 10.1002/j.1460-2075.1988.tb03044.x.
9
Correlation of beta-bend conformations of tetrapeptides with their activities in CD4-receptor binding assays.
Int J Pept Protein Res. 1989 Oct;34(4):325-32. doi: 10.1111/j.1399-3011.1989.tb01582.x.
10
Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
J Protein Chem. 1989 Dec;8(6):749-56. doi: 10.1007/BF01024899.